BG104405A - The application of thiazolidindions for the treatment of hyperglycaemia - Google Patents

The application of thiazolidindions for the treatment of hyperglycaemia

Info

Publication number: BG104405A
Authority: BG; Bulgaria
Prior art keywords: hyperglycaemia; treatment; thiazolidindions; application; sensibilizer
Prior art date: 1997-10-13

Application number

BG104405A

Other languages

Bulgarian (bg)

English (en)

Inventor

Robin Buckingham

Stephen Smith

Original Assignee

Smithkline Beecham P.L.C.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-10-13

Filing date

2000-05-05

Publication date

2000-12-29

2000-05-05 Application filed by Smithkline Beecham P.L.C. filed Critical Smithkline Beecham P.L.C.

2000-12-29 Publication of BG104405A publication Critical patent/BG104405A/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Endocrinology (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Hematology (AREA)
Obesity (AREA)
Chemical Kinetics & Catalysis (AREA)
Emergency Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Thiazole And Isothizaole Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Plural Heterocyclic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

BG104405A 1997-10-13 2000-05-05 The application of thiazolidindions for the treatment of hyperglycaemia BG104405A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9721692.3A GB9721692D0 (en)	1997-10-13	1997-10-13	Novel treatment
PCT/GB1998/003067 WO1999018944A1 (en)	1997-10-13	1998-10-12	Use of thiazolidinediones for the treatment of hyperglycaemia

Publications (1)

Publication Number	Publication Date
BG104405A true BG104405A (en)	2000-12-29

Family

ID=10820481

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BG104405A BG104405A (en)	1997-10-13	2000-05-05	The application of thiazolidindions for the treatment of hyperglycaemia

Country Status (24)

Country	Link
EP (1)	EP1023057A1 (xx)
JP (1)	JP2001519383A (xx)
KR (1)	KR20010024482A (xx)
CN (1)	CN1281358A (xx)
AP (1)	AP1223A (xx)
AU (1)	AU9547198A (xx)
BG (1)	BG104405A (xx)
BR (1)	BR9815220A (xx)
CA (1)	CA2305289A1 (xx)
CZ (1)	CZ20001298A3 (xx)
EA (1)	EA200000418A1 (xx)
GB (1)	GB9721692D0 (xx)
HR (1)	HRP20000256A2 (xx)
HU (1)	HUP0003673A3 (xx)
ID (1)	ID24439A (xx)
IL (1)	IL135515A0 (xx)
NO (1)	NO20001897L (xx)
OA (1)	OA11519A (xx)
PL (1)	PL339804A1 (xx)
SK (1)	SK5322000A3 (xx)
TR (1)	TR200000957T2 (xx)
UA (1)	UA66809C2 (xx)
WO (1)	WO1999018944A1 (xx)
YU (1)	YU28700A (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7045519B2 (en)	1998-06-19	2006-05-16	Chiron Corporation	Inhibitors of glycogen synthase kinase 3
CN1310620A (zh) *	1998-07-21	2001-08-29	史密丝克莱恩比彻姆有限公司	利用葡萄糖摄入增强剂减少编程性细胞死亡

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3856378T2 (de) *	1987-09-04	2000-05-11	Beecham Group P.L.C., Brentford	Substituierte Thiazolidindionderivate
GB9218830D0 (en) *	1992-09-05	1992-10-21	Smithkline Beecham Plc	Novel compounds
US5478852C1 (en) *	1993-09-15	2001-03-13	Sankyo Co	Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of impaired glucose tolerance in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus

1997
- 1997-10-13 GB GBGB9721692.3A patent/GB9721692D0/en not_active Ceased
1998
- 1998-10-12 CA CA002305289A patent/CA2305289A1/en not_active Abandoned
- 1998-10-12 AU AU95471/98A patent/AU9547198A/en not_active Abandoned
- 1998-10-12 SK SK532-2000A patent/SK5322000A3/sk unknown
- 1998-10-12 HU HU0003673A patent/HUP0003673A3/hu unknown
- 1998-10-12 YU YU28700A patent/YU28700A/sh unknown
- 1998-10-12 HR HR20000256A patent/HRP20000256A2/hr not_active Application Discontinuation
- 1998-10-12 BR BR9815220-3A patent/BR9815220A/pt not_active Application Discontinuation
- 1998-10-12 ID IDW20000670A patent/ID24439A/id unknown
- 1998-10-12 OA OA1200000107A patent/OA11519A/en unknown
- 1998-10-12 WO PCT/GB1998/003067 patent/WO1999018944A1/en not_active Ceased
- 1998-10-12 CZ CZ20001298A patent/CZ20001298A3/cs unknown
- 1998-10-12 PL PL98339804A patent/PL339804A1/xx unknown
- 1998-10-12 KR KR1020007003935A patent/KR20010024482A/ko not_active Ceased
- 1998-10-12 JP JP2000515579A patent/JP2001519383A/ja active Pending
- 1998-10-12 UA UA2000042049A patent/UA66809C2/uk unknown
- 1998-10-12 EA EA200000418A patent/EA200000418A1/ru unknown
- 1998-10-12 EP EP98949088A patent/EP1023057A1/en not_active Withdrawn
- 1998-10-12 AP APAP/P/2000/001788A patent/AP1223A/en active
- 1998-10-12 TR TR2000/00957T patent/TR200000957T2/xx unknown
- 1998-10-12 CN CN98812016A patent/CN1281358A/zh active Pending
- 1998-10-12 IL IL13551598A patent/IL135515A0/xx unknown
2000
- 2000-04-12 NO NO20001897A patent/NO20001897L/no not_active Application Discontinuation
- 2000-05-05 BG BG104405A patent/BG104405A/xx unknown

Also Published As

Publication number	Publication date
NO20001897D0 (no)	2000-04-12
AU9547198A (en)	1999-05-03
KR20010024482A (ko)	2001-03-26
EA200000418A1 (ru)	2000-10-30
IL135515A0 (en)	2001-05-20
BR9815220A (pt)	2000-11-14
CN1281358A (zh)	2001-01-24
OA11519A (en)	2004-02-09
CA2305289A1 (en)	1999-04-22
EP1023057A1 (en)	2000-08-02
CZ20001298A3 (cs)	2001-08-15
HRP20000256A2 (en)	2000-12-31
PL339804A1 (en)	2001-01-02
HUP0003673A3 (en)	2001-12-28
GB9721692D0 (en)	1997-12-10
AP2000001788A0 (en)	2000-06-30
ID24439A (id)	2000-07-20
JP2001519383A (ja)	2001-10-23
SK5322000A3 (en)	2000-09-12
HUP0003673A2 (hu)	2001-10-28
YU28700A (sh)	2003-10-31
TR200000957T2 (tr)	2000-08-21
WO1999018944A1 (en)	1999-04-22
AP1223A (en)	2003-11-13
NO20001897L (no)	2000-06-09
UA66809C2 (uk)	2004-06-15

Publication	Publication Date	Title
AU5263496A (en)	1996-10-23	Targeted catheter drug administration
AU3215597A (en)	1998-03-19	Method of inhibiting fibrosis with a somatostatin agonist
ZA97831B (en)	1997-10-31	Sustained delivery of an active agent using an implantable system.
AU9028798A (en)	1999-03-16	Method of improving drug treatment
AU6957596A (en)	1997-03-19	Implantable drug delivery apparatus
AU5576296A (en)	1996-11-18	Shuttle stent delivery catheter
WO1999004772A3 (en)	1999-04-08	Use of levobupivacaine
GR3029396T3 (en)	1999-05-28	Cosolvent parenteral formulation of tirilazad
AU1683995A (en)	1995-08-08	Intravenous administration of psoralen
AU4934496A (en)	1996-10-02	Method for in vitro preconditioning of myoblasts before transplantation
ZA944347B (en)	1995-02-15	The use of cetrorelix and other nona- and decapeptides in the preparation of a medicament for combating aids and for growth stimulation
AU9021298A (en)	1999-03-08	Agmatine as a treatment for neuropathic pain
MY118156A (en)	2004-09-30	Oral compositions of levosimendan.
AU1513397A (en)	1998-09-10	Cyclic analogs of PTH and PTHrP
BG104059A (en)	2000-10-31	Diabetes treatment with rosiglytazone and insulin
CA2253130A1 (en)	1999-05-06	A medicament for treating obesity and improving lipid metabolism
WO1999033450A3 (en)	1999-09-02	Pharmaceutical composition containing sibutramine and orlistat
AU1306795A (en)	1995-07-10	Anticonvulsant pseudofructopyranose sulfamates
CA2218145A1 (en)	1998-10-14	Method of treating dilated cardiomyopathy
AU2559995A (en)	1995-12-18	Transdermal delivery of anti-epileptic drugs
EP0744176A3 (en)	2002-05-15	Methods for inhibiting bone loss
AU7092196A (en)	1997-04-28	Administration of biologically active material
BG104405A (en)	2000-12-29	The application of thiazolidindions for the treatment of hyperglycaemia
BG104058A (en)	2000-10-31	Diabetes treatment with thiazolydindion and sulphonylurea
TW330933B (en)	1998-05-01	Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes